The case underscores the intricate interplay between genetic predisposition, tumor biology, and treatment response, emphasizing the imperative for further research to comprehend the underlying mechanisms driving the occurrence and aggressive nature of glioblastoma in the context of NF1. This evidence concerns the gene NF1 and neoplasm.